Health Care Supplies

Medtecs

Medtecs released FY2025 Q4 earnings on February 26, 2026 (SGT), with actual revenue of SGD 27.3 M and actual EPS of SGD -0.0059

Medtecs released FY2025 Annual Earnings on February 26, 2026 (SGT), with actual revenue of SGD 102.41 M and EPS of SGD -0.0113

Medtecs released FY2025 9 Months earnings on February 26, 2026 (SGT), actual revenue SGD 75.13 M, actual EPS SGD -0.0054

Medtecs released FY2025 Q3 earnings on February 26, 2026 (SGT) with actual revenue of SGD 27.43 M and EPS of SGD -0.0058

Medi-Globe Healthcare Reports 45.1% Revenue Growth in FY2025

Medtecs to Release FY2025 Earnings Report on March 1, 2026 (SGT)

Medtecs released FY2025 Q1 earnings on August 13 (SGT), actual revenue SGD 24.44 M, actual EPS SGD 0

Medtecs released FY2025 Q2 earnings on August 13, 2025 (SGT) with actual revenue of SGD 23.25 M and EPS of SGD 0.0002

Medtecs released FY2025 semi-annual earnings on August 13 (SGT), actual revenue SGD 47.7 M, actual EPS SGD 0.0004

Medtecs International Corporation Signs Joint Venture Agreement with Shijiazhuang Hongrui Group

Medtecs released FY2024 Q3 earnings on February 27, 2025 (SGT) with actual revenue of SGD 18.5 M and EPS of SGD -0.0217

Medtecs released FY2024 9 Months Earnings on February 27, 2025 (SGT) with actual revenue of SGD 53.02 M and EPS of SGD -0.0314

Medtecs released FY2024 Q4 earnings on February 27 After-Market SGT, actual revenue SGD 19.66 M, actual EPS SGD -0.0231

Medtecs released FY2024 annual earnings on February 27 After-Market SGT, actual revenue SGD 72.8 M (forecast SGD 190.87 M), actual EPS SGD -0.055

SingtelMBeCW260730

Abundance

Geely MB ePW261005

Asiatic

HSI 28000MBePW260629

Alibaba MB eCW260703

Teho

NKY 55000MBePW260911

NKY 52000MBePW260612

Jadason

Medtecs International Corporation Ltd. announced that the winding-up of its subsidiary Resilient Medical is not expected to materially affect its financials for FY2026. The High Court of Singapore will hear the liquidation application on February 3, 2026. The company reassured shareholders that the dissolution will not significantly impact net tangible assets or earnings per share, while advising caution in trading its shares. Medtecs operates in the medical and healthcare sector and is listed on the Singapore Exchange’s Catalist board.

Tip Ranks

Medtecs Says Resilient Medical Winding-Up Not Expected to Hit FY2026 Financials

Medtecs International Corporation Ltd. has appointed Wang Bo-Shing Jim as an independent director, effective February 12, 2026, while independent director Nieh Chien-Chung resigns. Wang will chair the remuneration committee and serve on the audit and nominating committees, enhancing the company's focus on independent oversight and corporate governance. These changes align with SGX requirements, reflecting Medtecs' commitment to governance in the healthcare sector.

Medtecs Reshapes Board with New Independent Director and Committee Changes

Medtecs International Corporation Ltd. is awaiting a final court order for the dissolution of its subsidiary, Resilient Medical. The process is not expected to significantly impact the company's financial metrics for 2025. Shareholders are advised to exercise caution in trading, and updates will be provided on significant developments. Medtecs operates in the medical industry, focusing on medical supplies and services.

Medtecs Awaits Court Order on Resilient Medical Dissolution

Medtecs International Corporation Limited showcased its global capabilities at MEDICA and A+A exhibitions in Germany, emphasizing its commitment to quality and sustainability in healthcare. The company, with over 35 years of experience, leverages its production capacity in Southeast Asia to provide high-quality protective products. Medtecs will participate in A+A 2025 and MEDICA 2025, highlighting its innovative medical protective equipment and partnerships, including a joint venture with Hongray Group for glove manufacturing in Cambodia. The company focuses on customized services, ESG practices, and advanced automation to enhance manufacturing efficiency and meet global healthcare demands.

prnewswire

04:43 ET
			
			
				Medtecs Showcases Global Capabilities at MEDICA and A+A in Germany - Advancing Global Partnerships through Competitive Pricing, Assured Quality, and Reliable Delivery

On October 2, 2025, in Taipei, there is a notable surge in artificial intelligence, digitalization, and smart healthcare technologies. These advancements are opening up new prospects for global health services but are also bringing about substantial challenges and transformative changes in the medical sector. This shift is leading to the need for rapid adaptation in order to keep up with the changing landscape.

Unusual Whales

Medtecs displays global strengths at MEDICA and A+A in Germany, focusing on competitive pricing, quality, and delivery.Char: 96

Medtecs International Corporation Ltd. is awaiting a court order regarding the dissolution of its subsidiary, Resilient Medical, which is in liquidation. The company believes this will not significantly affect its net tangible assets or earnings per share for the financial year ending December 31, 2025. Shareholders and potential investors are encouraged to stay updated on future announcements. Medtecs has an average trading volume of 1,282,216 and a current market cap of S$69.39M.

Medtecs Awaits Court Order on Resilient Medical’s Dissolution

Medtecs International Corporation Ltd. has announced a change in its company secretary, appointing Ms. Yao Enci, Eunice, effective September 1, 2025. She replaces Mr. Abdul Jabbar Bin Karam Din, to whom the Board expressed gratitude for his services. This change is part of the company's administrative updates and commitment to effective corporate governance.

Medtecs International Announces Change in Company Secretary

Medtecs International Corporation Ltd. has announced the winding up of its subsidiary, Resilient Medical Pte. Ltd., following a court order. Mr. Wong Pheng Cheong Martin has been appointed as the liquidator. The financial implications for Medtecs, particularly regarding net tangible assets and earnings per share, are under assessment. The company will provide monthly updates to stakeholders on any material developments. Medtecs operates in the medical industry and has a current market cap of S$74.86M.

Medtecs Subsidiary Resilient Medical to be Wound Up

Medtecs(546.SG)